Multiparametric MRI radiomics nomogram predicts synchronous distant metastasis in rectal cancer.

Journal: Scientific reports
Published Date:

Abstract

This study aimed to evaluate the utility of a multiparametric MRI-based radiomics nomogram for identifying patients with rectal cancer (RC) at high risk of synchronous distant metastasis (SDM). A fusion feature selection strategy, which combined univariate analysis with three machine learning algorithms, was employed to optimize predictive signatures from the 1,688 radiomics features extracted using PyRadiomics. A retrospective cohort of 169 RC patients (stratified into training and test sets at an 8:2 ratio, n = 134/35) was analyzed. Among these, 48.5% (82/169) presented with SDM. Following the screening process, four clinical characteristics were selected. Feature selection yielded eight features from diffusion-weighted (DW) images, eight from T2-weighted (T2W) images, and six from the combined radiomics model (integrating DW and T2W phases). The clinical-radiomics nomogram demonstrated superior predictive performance over standalone clinical or radiomics models, achieving areas under the curve (AUC) of 0.93 (95% CI: 0.89-0.96) and 0.94 (95% CI: 0.79-0.97) in the training and test cohorts, respectively, with balanced sensitivity (0.85-0.88) and specificity (0.86-0.89). The calibration plots demonstrated alignment between the nomogram's predictions and actual outcomes. Decision curve analysis (DCA) indicated that the nomogram model provided the highest net benefit across both the training and test sets, outperforming the standalone clinical and radiomics models. Consequently, this MRI-based radiomics nomogram could assist in the preoperative identification of RC patients at high SDM risk, thereby optimizing clinical management strategies.

Authors

  • Hao Jiang
    Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , 555 Zuchongzhi Road, Shanghai 201203, China.
  • Wei Guo
    Emergency Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Xue Lin
    Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China.
  • Zhuo Yu
    Huiying Medical Technology (Beijing) Co. Ltd., Beijing, 100192.
  • Yudie Qin
    Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150086, China.
  • Zhongqi Sun
    Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150086, China.
  • Hongbo Hu
    Center for Immunology and Hematology, State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu, China.
  • Jinping Li
    Department of Laboratory Medicine, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China, yzsbh.com.
  • Linhan Zhang
    Department of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Qiong Wu
    Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), 30 South Puzhu Road, Nanjing 211816, P. R. China.
  • Huijie Jiang
    Department of Radiology, The Second Affiliated Hospital of Harbin Medical University, No. 246, Xuefu Road, Nangang District, Harbin, 150086, China. [email protected].

Keywords

No keywords available for this article.